Seen in the press: Nemera Device Equivalence program on Pulmonary & Nasal Delivery magazine

NEMERA NEWS

Seen in the press: Nemera Device Equivalence program in ‘Pulmonary & Nasal Delivery’ magazine

November 2017 issue of  OnDrug Delivery Magazine, which is focused on pulmonary and nasal delivery, shows our Device Equivalence program on the cover and illustrates it in an article.


On pages 22-27, you can find an article with Pascale Farjas (Global Category Manager for ENT products), Alain Regard, (Technology Product Manager), and Céline Petitcolas (Customer Technical Support). In this artcle, they discuss the steps taken when designing a nasal spray device for the growing bioequivalence market.

equivalence
For more information on our Device Equivalence program, meet us at RDD, which will take place in Tucson, on 22-26 April.


The full article:

The full issue of the magazine:

Laboratory testing page


About Nemera

Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.

Nemera’s services and products cover several key delivery routes: Ophthalmic, Nasal, Buccal, Auricular, Inhalation, Dermal/Transdermal and Parenteral.

Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and contract manufacturing.